Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

MRI Labeling For Boston Scientific's Emblem MRI S-ICD Approved By US FDA

Executive Summary

Boston Scientific cardiac rhythm management has been struggling to compete with MRI-compatible devices from rival Medtronic.

Advertisement

Related Content

Abbott Finally Joins MRI-Compatibility Club In US CRM Market
Earnings Winners And Losers: BSX, BCR, NUVA, NVCR
HRS 2016 ROUND-UP: Medtronic Unveils New “Extravascular ICD”
APPROVALS ANALYSIS: Big Month For Cardio Devices, But Down Overall
Earnings Winners And Losers: BSX, CYNO, EW, GB, STJ, BCR, EXAC
APPROVALS ANALYSIS: MR-Compatible CRM Devices Lead Big Cardiovascular Crop
Boston Scientific gets early nod for next-gen S-ICD

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT103703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel